2024
SHEA position statement on pandemic preparedness for policymakers: emerging infectious threats.
Hsu V, Pergam S, Shenoy E, Banach D, Jones Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Jump R, Malani A, Mathew T, Murthy R, Weber D. SHEA position statement on pandemic preparedness for policymakers: emerging infectious threats. Infection Control And Hospital Epidemiology 2024, 1-3. PMID: 39028203, DOI: 10.1017/ice.2024.64.Peer-Reviewed Original ResearchSHEA position statement on pandemic preparedness for policymakers: introduction and overview.
Hsu V, Haessler S, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: introduction and overview. Infection Control And Hospital Epidemiology 2024, 1-3. PMID: 38835222, DOI: 10.1017/ice.2024.66.Peer-Reviewed Original ResearchHealthcare systemHealthcare delivery systemPublic health systemUS healthcare systemPublic health surveillanceDistribution of healthcareHealthcare workforceCare sitesNursing homesEmergency careHealth systemImproved life expectancyEssential suppliesHealth surveillanceLessons of COVID-19Pre-existing problemsHealthcarePosition statementPersonal protective equipmentCareWorld Health Organization Global Influenza Surveillance NetworkLife expectancySocioeconomic outcomesAging populationGlobal Influenza Surveillance NetworkSHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce.
Banach D, Mathew T, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: building a strong and resilient healthcare workforce. Infection Control And Hospital Epidemiology 2024, 1-4. PMID: 38835227, DOI: 10.1017/ice.2024.62.Peer-Reviewed Original ResearchHealthcare personnelHealthcare workforceMental health impact of COVID-19US healthcare workforceHealth impact of COVID-19Shortage of cliniciansMental health impactsInfection prevention programsCOVID-19 pandemicHealthcare personnel infectionInpatient careHealthcare organizationsHealthcare epidemiologistsPost-acutePandemic preparednessPrevention programsInfection preventionCOVID-19Delegate tasksPosition statementWorkforce resilienceHealthcareImpact of COVID-19Increased workload demandsFamily membersSociety for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages.
Weber D, Malani A, Shenoy E, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Mathew T, Murthy R, Pergam S. Society for Healthcare Epidemiology of America position statement on pandemic preparedness for policymakers: mitigating supply shortages. Infection Control And Hospital Epidemiology 2024, 1-5. PMID: 38835229, DOI: 10.1017/ice.2024.67.Peer-Reviewed Original ResearchPersonal protective equipmentSociety for Healthcare EpidemiologyComponents of infection controlStockpiling of personal protective equipmentPublic health responseNational Strategic StockpileHealthcare settingsShortage of personal protective equipmentHealth responseSupply chain deficienciesDiagnostic testsInfection controlPosition statementChain deficiencySupply chain failuresProducts ActMedical equipmentPandemic preparednessProtective equipmentUnited StatesRecommendationsSupply shortagesMitigate shortagesDefense Production ActSHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and release.
Branch-Elliman W, Banach D, Batshon L, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Shenoy E, Weber D. SHEA position statement on pandemic preparedness for policymakers: pandemic data collection, maintenance, and release. Infection Control And Hospital Epidemiology 2024, 1-5. PMID: 38835230, DOI: 10.1017/ice.2024.65.Peer-Reviewed Original ResearchSHEA position statement on pandemic preparedness for policymakers: the role of healthcare epidemiologists in communicating during infectious diseases outbreaks.
Shenoy E, Banach D, Batshon L, Branch-Elliman W, Dumyati G, Haessler S, Hsu V, Jump R, Malani A, Mathew T, Murthy R, Pergam S, Seeger M, Weber D. SHEA position statement on pandemic preparedness for policymakers: the role of healthcare epidemiologists in communicating during infectious diseases outbreaks. Infection Control And Hospital Epidemiology 2024, 1-5. PMID: 38836649, DOI: 10.1017/ice.2024.63.Peer-Reviewed Original ResearchPalm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection
Li Z, Zhang S, Zhang J, Avery L, Banach D, Zhao H, Liu C. Palm‐Sized Lab‐In‐A‐Magnetofluidic Tube Platform for Rapid and Sensitive Virus Detection. Advanced Science 2024, 11: 2310066. PMID: 38634211, PMCID: PMC11187901, DOI: 10.1002/advs.202310066.Peer-Reviewed Original ResearchDetect SARS-CoV-2Molecular diagnostics of infectious diseasesMolecular diagnosticsMolecular detection of virusesSARS-CoV-2Point-of-care molecular diagnosticsDiagnostics of infectious diseasesNucleic acid extractionMolecular detection methodsViral lysisNucleic acid sample preparationSensitive molecular diagnosticsAccurate molecular diagnosticsCRISPR detectionEarly treatmentSensitive virus detectionDetection of virusesClinical utilityNucleic acid amplificationHIV virusEarly treatment of diseaseIsothermal amplificationMagnetic beadsMicrocentrifuge tubesClinical samplesIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie International Edition 2024, 63: e202403123. PMID: 38516796, PMCID: PMC11073899, DOI: 10.1002/anie.202403123.Peer-Reviewed Original ResearchProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacerIntrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a
Zhang J, Li Z, Guo C, Guan X, Avery L, Banach D, Liu C. Intrinsic RNA Targeting Triggers Indiscriminate DNase Activity of CRISPR‐Cas12a. Angewandte Chemie 2024, 136 DOI: 10.1002/ange.202403123.Peer-Reviewed Original ResearchProtospacer adjacent motifTrans-cleavage activityUniversal assayCRISPR-Cas12a systemSingle-stranded DNAClinical samplesRNA substratesAdjacent motifRNA targetsRNA sensingDNA targetsNucleic acid detectionCas12a assayTranscription stepDNARNAMolecular diagnosticsHPV-16 DNADNA activityNucleic acid testingAcid detectionAssayHIV RNAClinical utilityProtospacerAn evaluation of outcomes and hospital readmissions among individuals with candidemia using statewide surveillance.
Suschana E, Correa M, Meek J, Banach D. An evaluation of outcomes and hospital readmissions among individuals with candidemia using statewide surveillance. Infection Control And Hospital Epidemiology 2024, 1-5. PMID: 38561197, DOI: 10.1017/ice.2024.52.Peer-Reviewed Original Research
2023
2191. An Assessment of Penicillin Allergy Documentation among Patients undergoing Elective Surgeries and Ambulatory Procedures
Banach D, Zavez K, Schramm C, Zolla M, Baron K, Carter E. 2191. An Assessment of Penicillin Allergy Documentation among Patients undergoing Elective Surgeries and Ambulatory Procedures. Open Forum Infectious Diseases 2023, 10: ofad500.1813. PMCID: PMC10678576, DOI: 10.1093/ofid/ofad500.1813.Peer-Reviewed Original ResearchPenicillin allergy recordsSymptoms of allergyElective surgeryAmbulatory proceduresPenicillin allergyAllergy recordsAntibiotic prescribingRisk stratificationMedical assistantsPost-operative adverse eventsPenicillin allergy historyRetrospective chart reviewPenicillin class antibioticsFuture antibiotic prescribingAllergy assessmentGastrointestinal symptomsAdverse eventsChart reviewAllergy historyAllergy documentationCommon symptomsAllergySurgeryPatient reactionsPatients2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut
Gleason-Vergados J, Correa M, Meek J, Banach D. 2466. The Evolution of Candidemia during the COVID-19 Pandemic in Connecticut. Open Forum Infectious Diseases 2023, 10: ofad500.2084. PMCID: PMC10677364, DOI: 10.1093/ofid/ofad500.2084.Peer-Reviewed Original ResearchIncidence rate ratiosIncidence rateCandidemia casesCOVID-19 pandemicNon-white race/ethnicityHospital-onset infectionsEpidemiology of candidemiaRate of candidemiaCOVID-19 treatmentCOVID-19 surgeFuture public health crisesLife-threatening bloodstream infectionsDifferent incidence ratesCOVID-19 case numbersRace/ethnicityCandidemia ratesClinical characteristicsPatient demographicsPublic health crisisInitial surgeMechanical ventilationBloodstream infectionsChi-square analysisCandidemia epidemiologyCandidemia841. An Evaluation of Outcomes and Hospital Readmissions Among Individuals with Candidemia in Connecticut (2019-2020)
Suschana E, Banach D, Meek J, Clogher P, Correa M. 841. An Evaluation of Outcomes and Hospital Readmissions Among Individuals with Candidemia in Connecticut (2019-2020). Open Forum Infectious Diseases 2023, 10: ofad500.886. PMCID: PMC10677324, DOI: 10.1093/ofid/ofad500.886.Peer-Reviewed Original ResearchHospital-onset infectionsEpisodes of candidemiaRisk factorsReadmission statusIncident episodesHospital readmissionHigh riskStatewide surveillance dataRetrospective cohort studyCommunity-onset infectionsCause of sepsisSpecific risk factorsNon-Candida albicans speciesClasses of infectionEvaluation of outcomesGeneral sepsisIncident admissionsReadmission characteristicsCandidemia episodesOverall morbidityCohort studySubsequent readmissionClinical factorsPrimary outcomeSignificant morbidity
2022
1373. Using Geospatial Analysis to Describe the Association between Active Tick Surveillance Data and Clinical Cases of Anaplasmosis
Desiato J, Banach D, Chan G, Palmeri M. 1373. Using Geospatial Analysis to Describe the Association between Active Tick Surveillance Data and Clinical Cases of Anaplasmosis. Open Forum Infectious Diseases 2022, 9: ofac492.1202. DOI: 10.1093/ofid/ofac492.1202.Peer-Reviewed Original ResearchCases of anaplasmosisClinical cases of anaplasmosisConnecticut Agricultural Experiment StationTick surveillanceActive tick surveillanceInfected ticksProportion of infected ticksTick infection prevalenceAgricultural Experiment StationIncidence rateIxodes scapularis ticksHuman casesAnaplasma infectionExperiment StationInfection prevalence dataTick infectionAnaplasmosisClinical casesVector-borne diseasesHuman anaplasmosisTicksNortheastern United StatesHuman incidence ratesTick surveillance dataInfection prevalenceEpidemiology and outcomes of surgical site infections among pediatric liver transplant recipients
Banach DB, Lopez‐Verdugo F, Sanchez‐Garcia J, Tran A, Gomez‐Llerena A, Munoz‐Abraham A, Bertacco A, Valentino PL, Yoo P, Dembry L, Mulligan DC, Ekong UD, Emre SH, Rodriguez‐Davalos M. Epidemiology and outcomes of surgical site infections among pediatric liver transplant recipients. Transplant Infectious Disease 2022, 24: e13941. PMID: 35989545, DOI: 10.1111/tid.13941.Peer-Reviewed Original ResearchConceptsSurgical site infectionLiver transplant recipientsLiver transplantationBiliary complicationsGraft recipientsTransplant recipientsSite infectionRisk factorsOutcomes of SSIPediatric liver transplant recipientsLong-term graftPediatric liver transplantationRetrospective descriptive analysisPrimary endpointHospital daysPatient agePediatric populationPatient survivalSignificant causeComplicationsPatientsRecipientsOutcomesInfectionIncidenceChanges in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance
Gleason-Vergados J, Clogher P, Meek J, Banach D. Changes in the microbiology, epidemiology, and outcomes of candidemia in Connecticut: A comparison between two periods using statewide surveillance. Infection Control And Hospital Epidemiology 2022, 44: 994-996. PMID: 36004535, DOI: 10.1017/ice.2022.38.Peer-Reviewed Original ResearchDecolonization Strategies for Infection Control of Gram-Negative Bacilli
Tailor N, Thomas D, Banach D. Decolonization Strategies for Infection Control of Gram-Negative Bacilli. 2022, 285-291. DOI: 10.1007/978-3-030-98427-4_24.ChaptersDecolonization strategiesFecal microbiota transplantationBurden of infectionGram-negative bacilliDecolonization regimensMicrobiota transplantationInfected patientsInfection controlHealthcare costsNegative pathogensHealthcare settingsNegative organismsAvailable evidenceSignificant increaseNegative bacteriaMorbidityRegimensPatientsTransplantationGlobal increaseInfectionMortalityIsolation Precautions for Visitors to Healthcare Settings
Cohen A, Simon M, Banach D. Isolation Precautions for Visitors to Healthcare Settings. 2022, 21-30. DOI: 10.1007/978-3-030-98427-4_4.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2021
1167. Hospital Readmissions among Infants Diagnosed with Early-Onset Neonatal Sepsis in Connecticut
Hudon R, Leung V, Leung V, Petit S, Banach D. 1167. Hospital Readmissions among Infants Diagnosed with Early-Onset Neonatal Sepsis in Connecticut. Open Forum Infectious Diseases 2021, 8: 675-675. PMCID: PMC8644067, DOI: 10.1093/ofid/ofab466.1360.Peer-Reviewed Original ResearchEarly-onset neonatal sepsisNeonatal sepsis casesNeonatal sepsisNon-white infantsInitial hospitalizationSepsis casesReadmission ratesClinical factorsStatewide hospital discharge databaseOne-year readmissionStatewide surveillance dataTiming of readmissionOnset neonatal sepsisHigher readmission ratesHospital discharge databaseHours of birthVulnerable patient populationSignificant infant morbidityPublic health surveillanceFirst yearPulmonary complicationsHospital readmissionInfant morbiditySystemic symptomsPatient populationSurveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two Periods
Gleason-Vergados J, Banach D, Clogher P, Meek J. Surveillance of Candidemia in Connecticut: An Epidemiological Comparison Between Two Periods. Antimicrobial Stewardship & Healthcare Epidemiology 2021, 1: s79-s80. PMCID: PMC9551423, DOI: 10.1017/ash.2021.156.Peer-Reviewed Original ResearchEmerging Infections ProgramEpidemiology of candidemiaCentral venous cathetersCommunity-onset infectionsVenous cathetersBlood culturesConnecticut residentsCDC's Emerging Infections ProgramCommon bloodstream infectionState-wide surveillanceExtended hospital stayIntravenous drug useAttributable mortality rateLength of stayPositive blood culturesCase report formsHigh treatment costsCandidemia managementCandidemia episodesHospital stayRecent surgeryPatient demographicsHospitalized patientsSignificant morbidityBloodstream infections